Purpose Body composition parameters including muscle and adipose tissue measurements
have emerged as prognostic factors in cancer patients. Besides cell cycle regulation, CDK 4 …

We evaluated the impact of body composition on clinical outcomes after neoadjuvant
chemotherapy (NAC) followed by surgery for elderly cStage II/III esophageal squamous cell …

Current data suggest that low skeletal muscle mass provides prognostic information in
patients with cancer and may even be considered a biomarker in research and clinical …

Background We aimed to evaluate the agreement between computed tomography (CT) and
surrogate methods applied in clinical practice for the assessment of low muscle mass. In …

Background: Low skeletal muscle index (SMI) and sarcopenia adversely affect clinical
outcomes in oncology patients. Study aims were to assess the agreement of bioelectrical …

Background Nutritional derangements are common hallmarks of non-small-cell lung cancer
(NSCLC). Nevertheless, their early detection is overlooked in clinical routine. This study …

Low muscle mass (LMM) and low muscle density (LMD) are increasingly recognized as
prognostic factors for survival in different malignancies. This study determined the …

Introduction Considering the high morbimortality rate in oncologic surgeries of the
gastrointestinal tract, especially in patients with malnutrition, the use of predictive tools is …

Background & aims Sarcopenia is prevalent in patients with liver cirrhosis and is negatively
associated with clinical outcomes. In a population screened for liver transplantation we …

Introduction Platinum–based chemotherapy is currently the most frequently applied first‐line
treatment for patients with advanced non‐small cell lung cancer (NSCLC) without targetable …